The Morning Risk Report
				
																	
								
				Biden administration bans U.S. sales of Kaspersky software, and banks are pressed to screen for money flow from fentanyl precursors. Also, Eli Lilly files more lawsuits at sellers of counterfeit Mounjaro, Zepbound.				
			
			
			
			
						
						
						
					
		